Edition:
United States

Alcobra Ltd (ADHD.OQ)

ADHD.OQ on NASDAQ Stock Exchange Global Market

1.13USD
19 Jul 2017
Change (% chg)

-- (--)
Prev Close
$1.13
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
65,975
52-wk High
$5.34
52-wk Low
$0.83

ADHD.OQ

Chart for ADHD.OQ

About

Alcobra Ltd is an Israel-based Biopharmaceutical company. It focuses on the development and commercialization of a proprietary drug, MG01CI, to treat Attention Deficit Hyperactivity Disorder (ADHD), a common and morbid neuropsychiatric condition in children and adults. Adult ADHD is associated with increased health risks and... (more)

Overall

Beta: 1.47
Market Cap(Mil.): $30.87
Shares Outstanding(Mil.): 27.56
Dividend: --
Yield (%): --

Financials

  ADHD.OQ Industry Sector
P/E (TTM): -- 212.65 15.78
EPS (TTM): -0.89 -- --
ROI: -42.22 -7.61 -8.29
ROE: -42.22 -9.04 -7.91

BRIEF-Alcobra announces cooperation agreement with Brosh Group

* Alcobra announces cooperation agreement with Brosh Group and board additions

Jun 12 2017

BRIEF-Alcobra names David Baker interim CEO, replacing Daniely

* Yaron Daniely to step down as chief executive officer, effective May 31, 2017

May 15 2017

BRIEF-Alcobra provides update on cancellation of extraordinary meeting called by Brosh Group

* Alcobra provides update on cancellation of extraordinary meeting called by Brosh Group

May 05 2017

BRIEF-Alcobra Ltd says mailed proxy materials for extraordinary general meeting of shareholders

* Alcobra Ltd - "mailed proxy materials for extraordinary general meeting of shareholders, called by Brosh Capital L.P. and certain of its affiliates"

Apr 24 2017

BRIEF-Amir Efrati says reports 16.8 pct stake in Alcobra as of April 12

* Amir Efrati - on April 12, delivered notice to Alcobra to convene independent extraordinary general meeting of shareholders - SEC filing

Apr 12 2017

BRIEF-Amir Efrati reports 16.8 pct stake in Alcobra Ltd

* Amir Efrati reports 16.8 percent stake in Alcobra Ltd as on April 6, 2017

Apr 10 2017

BRIEF-Amir Efrati reports passive stake of 9 pct in Alcobra Ltd

* Amir Efrati reports passive stake of 9 percent in alcobra ltd as on Feb. 22, 2017

Feb 24 2017

BRIEF-Alcobra reports Q4 loss per share $0.22

* Alcobra announces fourth-quarter and full-year 2016 financial results and provides corporate update

Feb 15 2017

BRIEF-Amir Efrati reports 7.5 pct stake in Alcobra Ltd as of Jan. 23

* Amir Efrati reports 7.5 percent stake in Alcobra Ltd as of January 23 - sec filing

Feb 02 2017

Earnings vs. Estimates